How does the VA rate hypertension?

Under 38 CFR 4.104 Diagnostic Code 7101. The brackets are based on diastolic AND systolic numbers (the higher bracket applies if either threshold is met): 10% requires diastolic pressure predominantly 100-109, OR systolic pressure predominantly 160-199, OR the veteran has a history of diastolic pressure predominantly 100 or more and now requires continuous medication for control; 20% requires diastolic predominantly 110-119 or systolic predominantly 200-219; 40% requires diastolic predominantly 120-129 or systolic predominantly 220 or more; 60% requires diastolic predominantly 130 or more.

Is hypertension now an Agent Orange presumptive?

Yes. The Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 (the PACT Act), Pub. L. 117-168, added hypertension to the list of Agent Orange presumptive diseases effective August 10, 2022. Hypertension is now included in 38 CFR 3.309(e) for veterans with qualifying service in the Republic of Vietnam, Thailand, Laos, Cambodia, Guam, American Samoa, Johnston Atoll, and Blue Water Navy areas. This was a major change — VA had previously denied hypertension AO claims for decades despite the National Academy of Medicine repeatedly finding evidence of association.

How do I refile a previously denied hypertension claim?

Submit VA Form 20-0995, Supplemental Claim, citing the PACT Act expansion of 38 CFR 3.309(e) as new and relevant evidence. Veterans previously denied because hypertension was not a presumptive condition can now succeed under the regulatory change. Effective date analysis: under 38 USC 5110(g) and the PACT Act's specific effective-date provisions for newly added presumptives, the effective date is typically the date of the original claim if the original claim was filed within one year of the regulatory change OR was continuously pursued. Otherwise the effective date is the date of the supplemental claim, or August 10, 2022 in some cases — the rules are technical and worth careful review.

Can hypertension be secondary to PTSD?

Yes. The mechanism is sympathetic nervous system dysregulation: PTSD produces chronic activation of the sympathetic axis and HPA-axis disruption, which over time elevates resting blood pressure and accelerates the onset of essential hypertension. The peer-reviewed literature supporting this pathway is extensive. The VA Adjudication Procedures Manual (M21-1) recognizes the secondary pathway. A nexus opinion from a cardiologist, internist, or psychiatrist stating that the veteran's hypertension is at least as likely as not caused or aggravated by service-connected PTSD via sympathetic dysregulation is the standard evidence package.

What counts as predominantly?

The DC 7101 brackets use the word predominantly for diastolic and systolic readings, meaning the majority of readings fall in the stated range. Practical interpretation: at least three readings over a period of time, with most of them in the bracket range. A single reading at 110 diastolic does not trigger the 20% bracket if 80% of readings are 100-105. The C&P examiner typically reviews readings over the prior six to twelve months.

What about hypertensive heart disease?

Hypertensive heart disease is rated separately under 38 CFR 4.104 Diagnostic Code 7007. Where hypertension has produced cardiomegaly, left ventricular hypertrophy, congestive heart failure, or coronary artery disease, those conditions support a higher rating under DC 7007 (METs-based, 10/30/60/100). Anti-pyramiding under 38 CFR 4.14 applies — the same heart condition cannot be rated twice under different codes, but the underlying hypertension and the resulting heart disease are distinct entities and rated separately.

What if my blood pressure is controlled by medication?

The 10% bracket includes the language for the veteran with a history of diastolic pressure predominantly 100 or more who requires continuous medication for control. Even with current readings normalized by medication, the historical record and current medication requirement support the 10% rating. The Federal Circuit in Saunders v. Wilkie, 886 F.3d 1356 (Fed. Cir. 2018), and earlier guidance confirm that the readings before treatment, plus continuous medication, satisfy the criterion. Do not let a C&P examiner or rater discount the rating based on current well-controlled numbers if the pre-medication history meets the threshold.

Does hypertension qualify for TDIU?

Generally not by itself unless it has produced severe organ damage. Most hypertension ratings cap at 10% or 20% and do not approach the schedular TDIU threshold. However, when combined with hypertensive heart disease, diabetes, PTSD, peripheral neuropathy, or other service-connected conditions, hypertension contributes to a combined rating that often meets the schedular TDIU threshold under 38 CFR 4.16(a).

Hypertension VA Rating

By Shirley Chia. Published 2026-05-31. Source: 38 CFR 4.104 (DC 7101), 38 CFR 3.309(e) (post-PACT presumptive).

TL;DR. Hypertension is rated under 38 CFR 4.104 DC 7101 at 10% (diastolic 100-109 or systolic 160-199 or history of diastolic 100+ on continuous medication), 20% (diastolic 110-119 or systolic 200-219), 40% (diastolic 120-129 or systolic 220+), or 60% (diastolic 130+). The PACT Act of 2022 added hypertension to the Agent Orange presumptive list under 38 CFR 3.309(e) effective August 10, 2022 — Vietnam-era veterans previously denied should refile via Supplemental Claim citing the regulatory change. Hypertension is also a documented secondary to PTSD via sympathetic dysregulation. Most hypertension ratings cap at 10% schedularly, but the strategic value is twofold: it locks in service connection for future increases as the disease progresses, and it supports separate ratings for hypertensive heart disease and end-organ complications.

The rating brackets under DC 7101

The 38 CFR 4.104 schedule for cardiovascular system includes DC 7101 (Hypertensive vascular disease — hypertension and isolated systolic hypertension). The brackets are based on diastolic AND systolic readings; the higher bracket applies if either threshold is met:

Rating	Diastolic	Systolic	2026 monthly comp (w/ spouse)
10%	Predominantly 100-109, OR history of diastolic predominantly 100+ requiring continuous medication for control	Predominantly 160-199	$211
20%	Predominantly 110-119	Predominantly 200-219	(combined per 4.25)
40%	Predominantly 120-129	Predominantly 220+	(combined per 4.25)
60%	Predominantly 130+	(no specific systolic cutoff at this level)	(combined per 4.25)

Note 1 to DC 7101

Hypertension or isolated systolic hypertension must be confirmed by readings taken two or more times on at least three different days. The diagnosis is procedural — three sets of readings on three different occasions before service connection attaches as a current disability.

The continuous-medication clause

The 10% bracket's third trigger — history of diastolic predominantly 100 or more requiring continuous medication for control — is the most underused element of DC 7101. It captures the veteran whose pre-treatment readings were in the 10% range but who is now well-controlled on antihypertensives.

Practical application: pull the medical record showing the readings before medication was initiated. If those readings were predominantly 100 or more diastolic, and the veteran is now on continuous medication, the 10% rating applies even if current readings are 130/85. Do not let a rater discount based on currently controlled numbers.

The PACT Act expansion

The Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022, Pub. L. 117-168 (PACT Act), enacted August 10, 2022, made the largest expansion of toxic-exposure presumptives in VA history. Among many other changes, the PACT Act added hypertension to the Agent Orange presumptive list under 38 CFR 3.309(e).

The factual backstory: the National Academy of Medicine's Veterans and Agent Orange biennial review process recommended that hypertension be moved to the "sufficient evidence of association" category as far back as 2018, after years in the "limited or suggestive evidence" category. VA repeatedly declined to add hypertension to 3.309(e) administratively. Congress then added it by statute via the PACT Act.

Qualifying service for AO hypertension

The same qualifying service that supports other AO presumptives now supports a hypertension presumptive claim:

Republic of Vietnam, January 9, 1962 to May 7, 1975 (boots-on-ground).
Inland waterways of Vietnam (brown water).
12 nautical miles of Vietnam coast (Blue Water Navy under Procopio and Pub. L. 116-23).
Specified Thai air bases, January 9, 1962 to June 30, 1976.
Laos, September 1, 1967 to September 1, 1968 (specific air base service).
Cambodia, near Mimot or Krek, April 16, 1969 to April 30, 1969.
Guam, American Samoa, Johnston Atoll, per PACT Act provisions and 38 CFR 3.307(a)(6).

Refiling previously denied claims

The path for a Vietnam-era veteran who was previously denied hypertension service connection (whether on direct or AO theory) is a Supplemental Claim under VA Form 20-0995, citing the PACT Act expansion as new and relevant evidence. The PACT Act includes specific effective-date provisions in section 406, providing that for claims received on or after August 10, 2022, the effective date is determined under standard rules. For claims received before August 10, 2022, but still pending, the effective date is the original claim date. For finally denied claims, refiling produces an effective date as early as the refiling date or August 10, 2022, depending on the facts.

The relevant retroactive-pay analysis is technical. Veterans who were continuously pursuing the claim (e.g., a denied claim followed by appeals that exhausted in the past year) may obtain earlier effective dates than veterans whose claims went finally denied a decade ago and are only now being refiled. See the PACT Act complete conditions guide for the broader effective-date framework.

The secondary-to-PTSD pathway

Hypertension secondary to PTSD is one of the most commonly granted secondary claims because the mechanism is documented in mainstream medicine. Sympathetic nervous system dysregulation produced by chronic PTSD elevates resting blood pressure through:

Persistent sympathetic activation (elevated norepinephrine).
HPA-axis dysregulation with altered cortisol patterns.
Impaired baroreflex sensitivity.
Chronic systemic inflammation.
Sleep fragmentation amplifying the above.

The VA Adjudication Procedures Manual (M21-1) recognizes the secondary pathway. The standard evidence package:

Service-connected PTSD already established.
Current hypertension diagnosis with the DC 7101 procedural confirmation (multiple readings on multiple days).
Nexus opinion from a cardiologist, internist, or psychiatrist stating that the veteran's hypertension is at least as likely as not (50% or more) caused or aggravated by the service-connected PTSD via sympathetic dysregulation, citing the literature.
Timeline showing hypertension onset after PTSD diagnosis or symptom onset.

See the nexus letter guide for the language that works and the language that does not.

Hypertensive heart disease — separate rating

When hypertension has produced structural heart disease (left ventricular hypertrophy, cardiomegaly, congestive heart failure, or coronary artery disease attributable to hypertensive damage), DC 7007 (Hypertensive heart disease) applies and is rated separately at 10%, 30%, 60%, or 100% based on workload METs, ejection fraction, and clinical history.

Anti-pyramiding under 38 CFR 4.14 prevents rating the same heart condition twice under different codes, but DC 7101 (hypertension itself) and DC 7007 (hypertensive heart disease) cover distinct entities and combine separately under 38 CFR 4.25.

Worked example

Air Force veteran, served at Korat Royal Thai Air Force Base 1972-1973 as a security policeman. Diagnosed with hypertension 1995. Filed AO presumptive claim 2010, denied because hypertension was not on the 3.309(e) list. Refiled 2024 under the PACT Act expansion.

Service eligibility. DD-214 confirms service at Korat between January 9, 1962 and June 30, 1976. As a security policeman serving along the air base perimeter (where herbicides were sprayed for vegetation control), the veteran has qualifying Thai air base service under the PACT Act expansion to 38 CFR 3.307(a)(6).

Current diagnosis. Hypertension diagnosed by primary care 1995. Pre-medication readings 1995: 158/104, 162/106, 160/102 across three visits in a six-month span. Started on lisinopril 1995; subsequently added hydrochlorothiazide 2003. Current readings on combination therapy 2024: 130/82, 128/85, 132/80 — well-controlled.

Rating analysis under DC 7101.

Pre-medication diastolic readings predominantly 100-109 (102, 104, 106 documented).
Currently requires continuous medication for control.
This triggers the third sub-clause of the 10% bracket: history of diastolic predominantly 100+ requiring continuous medication for control.
Current rating: 10%.

2026 monthly compensation. 10% rating with spouse = $211/month.

Effective date analysis.

Original AO claim filed 2010, denied 2011 (final).
Refiled via Supplemental Claim 2024 citing PACT Act expansion.
Under the PACT Act's effective-date provisions, the effective date for a refiled claim based on the regulatory expansion is generally the date of the supplemental claim (2024). The earlier denied claim was final and the regulatory change creates a new claim path, but the effective date follows the refiling date in most circumstances.
Specific exceptions can produce an earlier effective date back to August 10, 2022 in some cases. Veterans should review the PACT Act section 406 effective-date provisions with a VA-accredited attorney or VSO if substantial retroactive pay is at issue.

Strategic next steps for this veteran.

Monitor for end-organ damage: annual EKG, echocardiogram, and renal function testing. If left ventricular hypertrophy or coronary artery disease develops, claim DC 7007 (hypertensive heart disease) separately.
Check for ischemic heart disease — an AO presumptive that frequently coexists with hypertension. If coronary artery disease is documented (typically by stress test, catheterization, or imaging), it is independently presumptive under 3.309(e).
Consider Type 2 diabetes screening — also AO presumptive and frequently comorbid with hypertension in Vietnam-era veterans. See the Type 2 diabetes rating guide.

Sources cited in this article

38 CFR 4.104 Diagnostic Code 7101 (Hypertensive vascular disease)
38 CFR 3.309(e) (Diseases associated with exposure to certain herbicide agents)
38 CFR 3.307 (Presumptive service connection)
38 CFR 3.310 (Disabilities proximately due to or aggravated by service-connected disease or injury)
38 USC 1116 (Presumptions of service connection for diseases associated with exposure to certain herbicide agents)
38 USC 5110 (Effective dates of awards)
Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 (PACT Act), Pub. L. 117-168 (Aug. 10, 2022).
National Academy of Medicine, Veterans and Agent Orange: Update 11 (2018) (sufficient evidence of association between herbicide exposure and hypertension).
Procopio v. Wilkie, 913 F.3d 1371 (Fed. Cir. 2019) (en banc) (Blue Water Navy territorial sea presumption).

VetDisabilityCalc is an independent reference site. We are not VA-accredited and we do not prepare or present VA claims. This guide is reference material and is not legal advice.